Within microbial inactivation methods, antimicrobial efficacy is the capacity of a defined antimicrobial intervention—such as a chemical biocide, antimicrobial material, physical treatment, or biological agent—to inhibit microbial multiplication and/or to reduce the number of viable microorganisms under specified exposure conditions. It is an outcome-dependent property rather than an intrinsic synonym for the presence of antimicrobial activity: efficacy is defined only in relation to a target microorganism or microbial population, the magnitude and endpoint of the observed effect, and the controlled conditions of exposure, including agent concentration or intensity, contact time, temperature, growth state, inoculum, and test matrix ^[1][2].

The effect may be expressed as growth inhibition, loss of culturability, or microbial killing/inactivation, commonly quantified by minimum inhibitory or microbicidal concentrations, time–kill kinetics, or logarithmic reductions in viable counts ^[1][3]. Antimicrobial efficacy is therefore distinct from antimicrobial susceptibility, which characterizes the response of a microorganism to an agent under a defined test system, and from antimicrobial resistance, which denotes reduced susceptibility relative to an appropriate reference or interpretive framework. In the context of inactivation, a credible efficacy determination requires a specified microbial endpoint and standardized or otherwise explicitly described test conditions, because methodological variables directly affect the measured extent of microbial reduction ^[2][4].